Invention Grant
- Patent Title: Immunotherapy for angiogenic disease
-
Application No.: US16692598Application Date: 2019-11-22
-
Publication No.: US11413322B2Publication Date: 2022-08-16
- Inventor: Haruo Sugiyama
- Applicant: International Institute of Cancer Immunology, Inc.
- Applicant Address: JP Suita
- Assignee: International Institute of Cancer Immunology, Inc.
- Current Assignee: International Institute of Cancer Immunology, Inc.
- Current Assignee Address: JP Suita
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2014-251208 20141211
- Main IPC: C07K7/06
- IPC: C07K7/06 ; A61P27/02 ; C07K7/04 ; A61K38/02 ; A61K39/00 ; C07K14/47 ; A61K35/17 ; A61K9/00
Abstract:
The present invention provides a pharmaceutical composition containing a cancer antigen peptide for treatment and prevention of angiogenic diseases.
Public/Granted literature
- US20200078436A1 IMMUNOTHERAPY FOR ANGIOGENIC DISEASE Public/Granted day:2020-03-12
Information query
